Frontlight ResearchEarly access
CompletedNo phase
Effect of Norepinephrine Administration on Ventricular Systolic Function in Septic Shock
Key facts
- Who runs it
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Where
- Italy1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 30 people enrolled
- Started
- 10 Mar 2022
- Ended
- 20 May 2024
- Type of study
- Observational
- Record updated
- 21 May 2024
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (8)Hide the full registry criteria
Who can take part
- less than 6 hours from the diagnosis of septic shock
- ongoing vasopressor therapy by continuous intravenous infusion of norepinephrine
- treating physician's decision to increase norepinephrine dose
Who cannot take part
- myocardial disfunction due to active cardiac disease
- preload responsiveness assessed through dynamic indices
- pregnancy
- inadequate acoustic window for transthoracic echocardiography
- need for emergency treatment
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This observational, pharmacological, prospective study aims to assess the improvement of ventricular systolic function mediated by norepinephrine (NE) administration in preload non-responders septic shock patients. Left ventricular outflow tract velocity time integral (LVOT-VTI) is an echocardiographic index of ventricular systolic function and it will be measured at different NE dosages.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Effect of NorEpinephrine Administration on Ventricular Systolic Function in Septic Shock Patients: the ENESySS Study
- Record updated
- 21 May 2024